BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2017

Type / Class
Debt / NOTE 1.875% 4/2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2017 Q2 $0 $0 -$96,129,000 0
2017 Q1 $22,417,000 $96,129,000 +$21,000 425.0% 7
2016 Q4 $22,412,000 $90,665,000 -$48 402.27% 6
2016 Q3 $22,412,000 $101,554,000 -$7,511,500 450.0% 5
2016 Q2 $24,393,000 $92,546,000 -$20,166,153 379.5% 7
2016 Q1 $29,715,000 $119,304,000 -$6,004,077 400.0% 7
2015 Q4 $31,209,000 $160,347,000 -$1,007,177 510.2% 6
2015 Q3 $31,406,000 $161,790,000 -$96,000 509.09% 7
2015 Q2 $31,420,000 $210,856,000 -$1,412,000 672.08% 8
2015 Q1 $31,650,000 $193,917,000 -$35,778,228 613.64% 9
2014 Q4 $38,459,000 $175,983,000 -$20,191,000 445.93% 12
2014 Q3 $44,134,000 $160,616,000 -$19,547,704 356.58% 14
2014 Q2 $50,469,000 $158,317,000 -$45,446,552 307.53% 13
2014 Q1 $64,759,000 $217,180,000 +$19,758,509 336.76% 16